IL6 and cancer: Surprisingly, the requirement for IL-6 remains intrinsic to cancer cells and transplantable via the corresponding tumor organoids, thereby highlighting opportunities to discover therapeutic vulnerabilities over and above the addiction to IL-6 signaling identified here.